Is Antimicrobial Dosing Adjustment Associated with Better Outcomes in Patients with Severe Obesity and Bloodstream Infections? An Exploratory Study

The impact of adjusted treatment on clinical outcomes in patients with severe obesity is unclear. This study included adults with severe obesity admitted for bloodstream infections between 2005 and 2015. The patients were grouped according to the percentage of the appropriateness of the dosage of th...

Full description

Saved in:
Bibliographic Details
Published inAntibiotics (Basel) Vol. 9; no. 10; p. 707
Main Authors Sirard, Stéphanie, Abou Chakra, Claire Nour, Langlois, Marie-France, Perron, Julie, Carignan, Alex, Valiquette, Louis
Format Journal Article
LanguageEnglish
Published Basel MDPI AG 01.10.2020
MDPI
Subjects
Online AccessGet full text
ISSN2079-6382
2079-6382
DOI10.3390/antibiotics9100707

Cover

Abstract The impact of adjusted treatment on clinical outcomes in patients with severe obesity is unclear. This study included adults with severe obesity admitted for bloodstream infections between 2005 and 2015. The patients were grouped according to the percentage of the appropriateness of the dosage of their antimicrobial treatment: 80–100% = good, 20–79% = moderate, and 0–19% = poor. The association between antimicrobial adjustment and a composite of unfavourable outcomes [intensive care unit stay ≥72 h, duration of sepsis >3 days, length of stay ≥7 days or all-cause 30-day mortality] was assessed using logistic regression. Of 110 included episodes, the adjustment was rated good in 47 (43%) episodes, moderate in 31 (28%), and poor in 32 (29%). Older age, Pitt bacteremia score ≥2, sepsis on day 1, and infection site were independent risk factors for unfavourable outcomes. The level of appropriateness was not associated with unfavourable outcomes. The number of antimicrobials, consultation with an infectious disease specialist, blood urea nitrogen 7–10.9 mmol/L, and hemodialysis were significantly associated with adjusted antimicrobial dosing. While the severity of the infection had a substantial impact on the measured outcomes, we did not find an association between dosing optimization and better outcomes.
AbstractList The impact of adjusted treatment on clinical outcomes in patients with severe obesity is unclear. This study included adults with severe obesity admitted for bloodstream infections between 2005 and 2015. The patients were grouped according to the percentage of the appropriateness of the dosage of their antimicrobial treatment: 80–100% = good, 20–79% = moderate, and 0–19% = poor. The association between antimicrobial adjustment and a composite of unfavourable outcomes [intensive care unit stay ≥72 h, duration of sepsis >3 days, length of stay ≥7 days or all-cause 30-day mortality] was assessed using logistic regression. Of 110 included episodes, the adjustment was rated good in 47 (43%) episodes, moderate in 31 (28%), and poor in 32 (29%). Older age, Pitt bacteremia score ≥2, sepsis on day 1, and infection site were independent risk factors for unfavourable outcomes. The level of appropriateness was not associated with unfavourable outcomes. The number of antimicrobials, consultation with an infectious disease specialist, blood urea nitrogen 7–10.9 mmol/L, and hemodialysis were significantly associated with adjusted antimicrobial dosing. While the severity of the infection had a substantial impact on the measured outcomes, we did not find an association between dosing optimization and better outcomes.
The impact of adjusted treatment on clinical outcomes in patients with severe obesity is unclear. This study included adults with severe obesity admitted for bloodstream infections between 2005 and 2015. The patients were grouped according to the percentage of the appropriateness of the dosage of their antimicrobial treatment: 80-100% = good, 20-79% = moderate, and 0-19% = poor. The association between antimicrobial adjustment and a composite of unfavourable outcomes [intensive care unit stay ≥72 h, duration of sepsis >3 days, length of stay ≥7 days or all-cause 30-day mortality] was assessed using logistic regression. Of 110 included episodes, the adjustment was rated good in 47 (43%) episodes, moderate in 31 (28%), and poor in 32 (29%). Older age, Pitt bacteremia score ≥2, sepsis on day 1, and infection site were independent risk factors for unfavourable outcomes. The level of appropriateness was not associated with unfavourable outcomes. The number of antimicrobials, consultation with an infectious disease specialist, blood urea nitrogen 7-10.9 mmol/L, and hemodialysis were significantly associated with adjusted antimicrobial dosing. While the severity of the infection had a substantial impact on the measured outcomes, we did not find an association between dosing optimization and better outcomes.The impact of adjusted treatment on clinical outcomes in patients with severe obesity is unclear. This study included adults with severe obesity admitted for bloodstream infections between 2005 and 2015. The patients were grouped according to the percentage of the appropriateness of the dosage of their antimicrobial treatment: 80-100% = good, 20-79% = moderate, and 0-19% = poor. The association between antimicrobial adjustment and a composite of unfavourable outcomes [intensive care unit stay ≥72 h, duration of sepsis >3 days, length of stay ≥7 days or all-cause 30-day mortality] was assessed using logistic regression. Of 110 included episodes, the adjustment was rated good in 47 (43%) episodes, moderate in 31 (28%), and poor in 32 (29%). Older age, Pitt bacteremia score ≥2, sepsis on day 1, and infection site were independent risk factors for unfavourable outcomes. The level of appropriateness was not associated with unfavourable outcomes. The number of antimicrobials, consultation with an infectious disease specialist, blood urea nitrogen 7-10.9 mmol/L, and hemodialysis were significantly associated with adjusted antimicrobial dosing. While the severity of the infection had a substantial impact on the measured outcomes, we did not find an association between dosing optimization and better outcomes.
The impact of adjusted treatment on clinical outcomes in patients with severe obesity is unclear. This study included adults with severe obesity admitted for bloodstream infections between 2005 and 2015. The patients were grouped according to the percentage of the appropriateness of the dosage of their antimicrobial treatment: 80-100% = good, 20-79% = moderate, and 0-19% = poor. The association between antimicrobial adjustment and a composite of unfavourable outcomes [intensive care unit stay [greater than or equal to]72 h, duration of sepsis >3 days, length of stay [greater than or equal to]7 days or all-cause 30-day mortality] was assessed using logistic regression. Of 110 included episodes, the adjustment was rated good in 47 (43%) episodes, moderate in 31 (28%), and poor in 32 (29%). Older age, Pitt bacteremia score [greater than or equal to]2, sepsis on day 1, and infection site were independent risk factors for unfavourable outcomes. The level of appropriateness was not associated with unfavourable outcomes. The number of antimicrobials, consultation with an infectious disease specialist, blood urea nitrogen 7-10.9 mmol/L, and hemodialysis were significantly associated with adjusted antimicrobial dosing. While the severity of the infection had a substantial impact on the measured outcomes, we did not find an association between dosing optimization and better outcomes.
Audience Academic
Author Valiquette, Louis
Sirard, Stéphanie
Langlois, Marie-France
Perron, Julie
Abou Chakra, Claire Nour
Carignan, Alex
AuthorAffiliation 2 Department of Medicine, Division of Endocrinology, Université de Sherbrooke, Sherbrooke, QC J1H 5N4, Canada; marie-france.langlois@usherbrooke.ca
3 Department of Pharmacy, Centre Intégré Universitaire de Santé et de Services Sociaux de l’Estrie-Centre Hospitalier Universitaire de Sherbrooke, Granby, QC J2G 1T7, Canada; julie.perron2@usherbrooke.ca
1 Department of Microbiology and Infectious Diseases, Université de Sherbrooke, Sherbrooke, QC J1H 5N4, Canada; stephanie.sirard@USherbrooke.ca (S.S.); claire.nour.abou.chakra@usherbrooke.ca (C.N.A.C.); alex.carignan@usherbrooke.ca (A.C.)
AuthorAffiliation_xml – name: 3 Department of Pharmacy, Centre Intégré Universitaire de Santé et de Services Sociaux de l’Estrie-Centre Hospitalier Universitaire de Sherbrooke, Granby, QC J2G 1T7, Canada; julie.perron2@usherbrooke.ca
– name: 1 Department of Microbiology and Infectious Diseases, Université de Sherbrooke, Sherbrooke, QC J1H 5N4, Canada; stephanie.sirard@USherbrooke.ca (S.S.); claire.nour.abou.chakra@usherbrooke.ca (C.N.A.C.); alex.carignan@usherbrooke.ca (A.C.)
– name: 2 Department of Medicine, Division of Endocrinology, Université de Sherbrooke, Sherbrooke, QC J1H 5N4, Canada; marie-france.langlois@usherbrooke.ca
Author_xml – sequence: 1
  givenname: Stéphanie
  surname: Sirard
  fullname: Sirard, Stéphanie
– sequence: 2
  givenname: Claire Nour
  surname: Abou Chakra
  fullname: Abou Chakra, Claire Nour
– sequence: 3
  givenname: Marie-France
  surname: Langlois
  fullname: Langlois, Marie-France
– sequence: 4
  givenname: Julie
  orcidid: 0000-0001-7454-7840
  surname: Perron
  fullname: Perron, Julie
– sequence: 5
  givenname: Alex
  surname: Carignan
  fullname: Carignan, Alex
– sequence: 6
  givenname: Louis
  orcidid: 0000-0002-8300-8416
  surname: Valiquette
  fullname: Valiquette, Louis
BookMark eNp9kktvFDEMx0eoiD7oF-AUiQuXhbzmdQFtS4GVKi1S4Rx5Es82q5lkSTIt-zn4ws12K6BFIpdYzs9_O7aPiwPnHRbFK0bfCtHSd-CS7axPVseWUVrT-llxxGndzirR8IO_7MPiNMY1zadloqHNi-JQCNow1vKj4tciknmWGq0OvrMwkI8-Wrcic7OeYhrRJTKP0WsLCQ25temanGFKGMhyStqPGIl15Cskm9G4B67wBgOSZYfRpi0BZ8jZ4L2JKSCMZOF61Ml6Fz_k3OTi52bwAZIPW3KVJrN9WTzvYYh4-nCfFN8_XXw7_zK7XH5enM8vZ7qkLM2gNlpTTeuS96Voq5JBa1jHtEZWyb7usl1KZjSXsioBTCNFzaq-o5r3ICpxUiz2usbDWm2CHSFslQer7h0-rBSE3OABFZMd6ymTtWyYBNF3psMOGi0RJFIDWev9XmszdSManZsRYHgk-vjF2Wu18jeqrihv7ot58yAQ_I8JY1KjjRqHARz6KSouS97WDaVlRl8_Qdd-Ci63SvFSli1rKZd_qBXkD1jX-5xX70TVvJJcNKxiO4rvqTz-GAP2v0tmVO0WTf27aDmoeRKkbYLdRHMKO_wv9A4Oc9-I
CitedBy_id crossref_primary_10_1186_s12879_021_06682_8
Cites_doi 10.1016/j.amjmed.2008.01.046
10.2165/11318100-000000000-00000
10.1007/s11908-015-0493-6
10.1016/j.jinf.2017.09.009
10.1093/jac/dkv189
10.1007/s00134-017-4683-6
10.1016/j.ijantimicag.2012.09.004
10.1093/ije/dyx091
10.1016/j.ijantimicag.2016.01.009
10.1128/AAC.00531-19
10.1002/jcph.505
10.1002/phar.1327
10.1007/s11695-008-9477-z
10.1038/ijo.2012.62
10.1002/pds.3461
10.1007/s10096-016-2835-1
10.1097/SHK.0b013e318182f98f
10.1002/phar.2023
10.1002/j.1875-9114.2012.01098.x
10.1001/dmp.2010.40
10.1016/j.jemermed.2012.11.051
10.1093/cid/ciu296
10.1111/1469-0691.12195
10.7326/0003-4819-140-1-200401060-00008
10.1016/j.ajem.2018.09.011
10.2147/DDDT.S181834
10.1016/j.jiac.2016.07.006
10.1097/IPC.0000000000000711
10.1016/S1473-3099(06)70523-0
10.1097/MJT.0000000000000401
10.1056/NEJMoa1614362
10.1016/j.ajem.2011.05.027
10.1177/2150131915583659
10.1016/j.jinf.2012.03.013
ContentType Journal Article
Copyright COPYRIGHT 2020 MDPI AG
2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2020 by the authors. 2020
Copyright_xml – notice: COPYRIGHT 2020 MDPI AG
– notice: 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2020 by the authors. 2020
DBID AAYXX
CITATION
7QL
7T7
8FD
8FE
8FH
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
C1K
CCPQU
DWQXO
FR3
GNUQQ
HCIFZ
LK8
M7P
P64
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.3390/antibiotics9100707
DatabaseName CrossRef
Bacteriology Abstracts (Microbiology B)
Industrial and Applied Microbiology Abstracts (Microbiology A)
Technology Research Database
ProQuest SciTech Collection
ProQuest Natural Science Journals
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One
ProQuest Central
Engineering Research Database
ProQuest Central Student
SciTech Premium Collection
Biological Sciences
Biological Science Database
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
Publicly Available Content Database
ProQuest Central Student
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Natural Science Collection
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest Central
ProQuest One Applied & Life Sciences
Natural Science Collection
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Biological Science Collection
Industrial and Applied Microbiology Abstracts (Microbiology A)
ProQuest Central (New)
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
Biological Science Database
ProQuest SciTech Collection
Biotechnology and BioEngineering Abstracts
ProQuest One Academic UKI Edition
Engineering Research Database
ProQuest One Academic
ProQuest One Academic (New)
MEDLINE - Academic
DatabaseTitleList Publicly Available Content Database
CrossRef
MEDLINE - Academic



Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: BENPR
  name: ProQuest Central
  url: http://www.proquest.com/pqcentral?accountid=15518
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 2079-6382
ExternalDocumentID oai_doaj_org_article_14b1f01474814a3fbdbeba8c4ea4e0da
PMC7602836
A642381614
10_3390_antibiotics9100707
GeographicLocations Canada
GeographicLocations_xml – name: Canada
GroupedDBID 53G
5VS
8FE
8FH
AADQD
AAFWJ
AAHBH
AAYXX
ADBBV
AFKRA
AFPKN
AFZYC
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BBNVY
BCNDV
BENPR
BHPHI
CCPQU
CITATION
ECGQY
GROUPED_DOAJ
HCIFZ
HYE
IAO
IHR
KQ8
LK8
M48
M7P
MODMG
M~E
OK1
PGMZT
PHGZM
PHGZT
PIMPY
PROAC
RPM
7QL
7T7
8FD
ABUWG
AZQEC
C1K
DWQXO
FR3
GNUQQ
P64
PKEHL
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
7X8
PUEGO
5PM
ID FETCH-LOGICAL-c501t-a7dcc0c0752f539651a9d1b1cce164f7b1b1541dc24465aad843716fb0c2fa363
IEDL.DBID M48
ISSN 2079-6382
IngestDate Wed Aug 27 01:32:55 EDT 2025
Thu Aug 21 17:09:39 EDT 2025
Fri Sep 05 12:22:39 EDT 2025
Fri Jul 25 10:44:50 EDT 2025
Tue Jun 17 21:39:19 EDT 2025
Tue Jul 01 02:09:35 EDT 2025
Thu Apr 24 23:07:46 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 10
Language English
License https://creativecommons.org/licenses/by/4.0
Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c501t-a7dcc0c0752f539651a9d1b1cce164f7b1b1541dc24465aad843716fb0c2fa363
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-8300-8416
0000-0001-7454-7840
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.3390/antibiotics9100707
PMID 33081192
PQID 2545919024
PQPubID 2032437
ParticipantIDs doaj_primary_oai_doaj_org_article_14b1f01474814a3fbdbeba8c4ea4e0da
pubmedcentral_primary_oai_pubmedcentral_nih_gov_7602836
proquest_miscellaneous_2452978005
proquest_journals_2545919024
gale_infotracmisc_A642381614
crossref_primary_10_3390_antibiotics9100707
crossref_citationtrail_10_3390_antibiotics9100707
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2020-10-01
PublicationDateYYYYMMDD 2020-10-01
PublicationDate_xml – month: 10
  year: 2020
  text: 2020-10-01
  day: 01
PublicationDecade 2020
PublicationPlace Basel
PublicationPlace_xml – name: Basel
PublicationTitle Antibiotics (Basel)
PublicationYear 2020
Publisher MDPI AG
MDPI
Publisher_xml – name: MDPI AG
– name: MDPI
References Grissom (ref_22) 2010; 4
Stevens (ref_34) 2014; 59
Rahmatinejad (ref_23) 2019; 37
Rhee (ref_17) 2009; 31
Chung (ref_37) 2015; 55
Liang (ref_32) 2015; 17
Falagas (ref_2) 2006; 6
Nault (ref_24) 2017; 72
Hall (ref_28) 2008; 121
Longo (ref_8) 2013; 22
Alobaid (ref_5) 2016; 47
Charani (ref_27) 2015; 70
Davis (ref_29) 2013; 33
Abdullahi (ref_6) 2008; 18
Goto (ref_11) 2013; 19
Roe (ref_31) 2012; 30
Theofiles (ref_9) 2015; 6
Rhodes (ref_33) 2017; 43
Aretha (ref_26) 2016; 2016
Hanley (ref_4) 2010; 49
Winter (ref_21) 2012; 32
Meng (ref_19) 2017; 37
ref_25
ref_1
Rosini (ref_30) 2013; 44
Cox (ref_35) 2017; 75
Lam (ref_15) 2019; 63
Huttunen (ref_3) 2013; 37
Paterson (ref_18) 2004; 140
Lines (ref_16) 2019; 27
Lizza (ref_14) 2016; 22
Halilovic (ref_7) 2012; 65
Ibrahim (ref_10) 2018; 12
Paulsen (ref_12) 2017; 46
Srinivas (ref_20) 2018; 25
Cheatham (ref_36) 2013; 41
Atamna (ref_13) 2017; 36
References_xml – volume: 121
  start-page: 515
  year: 2008
  ident: ref_28
  article-title: Multicenter evaluation of vancomycin dosing: Emphasis on obesity
  publication-title: Am. J. Med.
  doi: 10.1016/j.amjmed.2008.01.046
– volume: 49
  start-page: 71
  year: 2010
  ident: ref_4
  article-title: Effect of obesity on the pharmacokinetics of drugs in humans
  publication-title: Clin. Pharmacokinet.
  doi: 10.2165/11318100-000000000-00000
– volume: 17
  start-page: 493
  year: 2015
  ident: ref_32
  article-title: Empiric antimicrobial therapy in severe sepsis and septic shock: Optimizing pathogen clearance
  publication-title: Curr. Infect. Dis. Rep.
  doi: 10.1007/s11908-015-0493-6
– volume: 75
  start-page: 486
  year: 2017
  ident: ref_35
  article-title: Clinical outcomes in patients hospitalized with cellulitis treated with oral clindamycin and trimethoprim-sulfamethoxazole: The role of weight-based dosing
  publication-title: J. Infect.
  doi: 10.1016/j.jinf.2017.09.009
– volume: 70
  start-page: 2906
  year: 2015
  ident: ref_27
  article-title: Antimicrobial therapy in obesity: A multicentre cross-sectional study
  publication-title: J. Antimicrob. Chemother.
  doi: 10.1093/jac/dkv189
– volume: 43
  start-page: 304
  year: 2017
  ident: ref_33
  article-title: Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
  publication-title: Intensive Care Med.
  doi: 10.1007/s00134-017-4683-6
– volume: 41
  start-page: 52
  year: 2013
  ident: ref_36
  article-title: Steady state pharmacokinetics and pharmacodynamics of piperacillin and tazobactam administered by prolonged infusion in obese patients
  publication-title: Int. J. Antimicrob. Agents
  doi: 10.1016/j.ijantimicag.2012.09.004
– volume: 46
  start-page: 1573
  year: 2017
  ident: ref_12
  article-title: Associations of obesity and lifestyle with the risk and mortality of bloodstream infection in a general population: A 15-year follow-up of 64 027 individuals in the HUNT Study
  publication-title: Int. J. Epidemiol.
  doi: 10.1093/ije/dyx091
– volume: 47
  start-page: 259
  year: 2016
  ident: ref_5
  article-title: Effect of obesity on the pharmacokinetics of antimicrobials in critically ill patients: A structured review
  publication-title: Int. J. Antimicrob. Agents
  doi: 10.1016/j.ijantimicag.2016.01.009
– volume: 63
  start-page: e00531-19
  year: 2019
  ident: ref_15
  article-title: Clinical and microbiological outcomes in obese patients receiving colistin for carbapenem-resistant gram-negative bloodstream infection
  publication-title: Antimicrob. Agents Chemother.
  doi: 10.1128/AAC.00531-19
– volume: 55
  start-page: 899
  year: 2015
  ident: ref_37
  article-title: Population pharmacokinetics and pharmacodynamics of piperacillin and tazobactam administered by prolonged infusion in obese and nonobese patients
  publication-title: J. Clin. Pharmacol.
  doi: 10.1002/jcph.505
– volume: 33
  start-page: 1256
  year: 2013
  ident: ref_29
  article-title: Adherence to the 2009 consensus guidelines for vancomycin dosing and monitoring practices: A cross-sectional survey of U.S. hospitals
  publication-title: Pharmacotherapy
  doi: 10.1002/phar.1327
– volume: 18
  start-page: 1450
  year: 2008
  ident: ref_6
  article-title: The eradication of Helicobacter pylori is affected by body mass index (BMI)
  publication-title: Obes. Surg.
  doi: 10.1007/s11695-008-9477-z
– volume: 37
  start-page: 333
  year: 2013
  ident: ref_3
  article-title: Obesity and the risk and outcome of infection
  publication-title: Int. J. Obes. (Lond.)
  doi: 10.1038/ijo.2012.62
– volume: 22
  start-page: 970
  year: 2013
  ident: ref_8
  article-title: The effect of obesity on antibiotic treatment failure: A historical cohort study
  publication-title: Pharmacoepidemiol. Drug Saf.
  doi: 10.1002/pds.3461
– volume: 36
  start-page: 585
  year: 2017
  ident: ref_13
  article-title: How obesity impacts outcomes of infectious diseases
  publication-title: Eur. J. Clin. Microbiol. Infect. Dis.
  doi: 10.1007/s10096-016-2835-1
– volume: 72
  start-page: 933
  year: 2017
  ident: ref_24
  article-title: Sustained impact of a computer-assisted antimicrobial stewardship intervention on antimicrobial use and length of stay
  publication-title: J. Antimicrob. Chemother.
– volume: 31
  start-page: 146
  year: 2009
  ident: ref_17
  article-title: Scoring systems for prediction of mortality in patients with intensive care unit-acquired sepsis: A comparison of the Pitt bacteremia score and the Acute Physiology and Chronic Health Evaluation II scoring systems
  publication-title: Shock
  doi: 10.1097/SHK.0b013e318182f98f
– volume: 37
  start-page: 1415
  year: 2017
  ident: ref_19
  article-title: Comprehensive guidance for antibiotic dosing in obese adults
  publication-title: Pharmacotherapy
  doi: 10.1002/phar.2023
– volume: 32
  start-page: 604
  year: 2012
  ident: ref_21
  article-title: Impact of various body weights and serum creatinine concentrations on the bias and accuracy of the Cockcroft-Gault equation
  publication-title: Pharmacotherapy
  doi: 10.1002/j.1875-9114.2012.01098.x
– volume: 4
  start-page: 277
  year: 2010
  ident: ref_22
  article-title: A modified sequential organ failure assessment score for critical care triage
  publication-title: Disaster Med. Public Health Prep.
  doi: 10.1001/dmp.2010.40
– volume: 44
  start-page: 979
  year: 2013
  ident: ref_30
  article-title: Prescribing habits of vancomycin in the Emergency Department: Are we dosing appropriately?
  publication-title: J. Emerg. Med.
  doi: 10.1016/j.jemermed.2012.11.051
– ident: ref_25
– volume: 2016
  start-page: 5941279
  year: 2016
  ident: ref_26
  article-title: The role of obesity in sepsis outcome among critically ill patients: A retrospective cohort analysis
  publication-title: Biomed. Res. Int.
– volume: 59
  start-page: e10
  year: 2014
  ident: ref_34
  article-title: Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America
  publication-title: Clin. Infect. Dis.
  doi: 10.1093/cid/ciu296
– volume: 19
  start-page: 501
  year: 2013
  ident: ref_11
  article-title: Overall burden of bloodstream infection and nosocomial bloodstream infection in North America and Europe
  publication-title: Clin. Microbiol. Infect.
  doi: 10.1111/1469-0691.12195
– volume: 140
  start-page: 26
  year: 2004
  ident: ref_18
  article-title: International prospective study of Klebsiella pneumoniae bacteremia: Implications of extended-spectrum beta-lactamase production in nosocomial infections
  publication-title: Ann. Intern. Med.
  doi: 10.7326/0003-4819-140-1-200401060-00008
– volume: 37
  start-page: 1237
  year: 2019
  ident: ref_23
  article-title: Predictive performance of the SOFA and mSOFA scoring systems for predicting in-hospital mortality in the emergency department
  publication-title: Am. J. Emerg. Med.
  doi: 10.1016/j.ajem.2018.09.011
– volume: 12
  start-page: 4171
  year: 2018
  ident: ref_10
  article-title: Best tigecycline dosing for treatment of infections caused by multidrug-resistant pathogens in critically ill patients with different body weights
  publication-title: Drug Des. Dev. Ther.
  doi: 10.2147/DDDT.S181834
– volume: 22
  start-page: 671
  year: 2016
  ident: ref_14
  article-title: Impact of body mass index on clinical outcomes in patients with gram-negative bacteria bloodstream infections
  publication-title: J. Infect. Chemother.
  doi: 10.1016/j.jiac.2016.07.006
– volume: 27
  start-page: 90
  year: 2019
  ident: ref_16
  article-title: Association between body mass index and mortality in patients with gram-negative bloodstream infections
  publication-title: Infect. Dis. Clin. Pract.
  doi: 10.1097/IPC.0000000000000711
– volume: 6
  start-page: 438
  year: 2006
  ident: ref_2
  article-title: Obesity and infection
  publication-title: Lancet Infect. Dis.
  doi: 10.1016/S1473-3099(06)70523-0
– volume: 25
  start-page: e224
  year: 2018
  ident: ref_20
  article-title: Influence of morbid obesity on the clinical pharmacokinetics of various anti-infective drugs: Reappraisal using recent case studies-issues, dosing implications, and considerations
  publication-title: Am. J. Ther.
  doi: 10.1097/MJT.0000000000000401
– ident: ref_1
  doi: 10.1056/NEJMoa1614362
– volume: 30
  start-page: 1212
  year: 2012
  ident: ref_31
  article-title: Underdosing of common antibiotics for obese patients in the ED
  publication-title: Am. J. Emerg. Med.
  doi: 10.1016/j.ajem.2011.05.027
– volume: 6
  start-page: 233
  year: 2015
  ident: ref_9
  article-title: Cellulitis in obesity: Adverse outcomes affected by increases in body mass index
  publication-title: J. Prim. Care Community Health
  doi: 10.1177/2150131915583659
– volume: 65
  start-page: 128
  year: 2012
  ident: ref_7
  article-title: Risk factors for clinical failure in patients hospitalized with cellulitis and cutaneous abscess
  publication-title: J. Infect.
  doi: 10.1016/j.jinf.2012.03.013
SSID ssj0000913808
Score 2.144578
Snippet The impact of adjusted treatment on clinical outcomes in patients with severe obesity is unclear. This study included adults with severe obesity admitted for...
SourceID doaj
pubmedcentral
proquest
gale
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Enrichment Source
Index Database
StartPage 707
SubjectTerms Antibiotics
Antiinfectives and antibacterials
Antimicrobial agents
antimicrobials
Bacteremia
Bacterial infections
bloodstream infection
Body mass index
Care and treatment
Clinical outcomes
Creatinine
Dosage
Dosage and administration
Drug dosages
Drug therapy
Gastrointestinal surgery
Health services
Hemodialysis
Hospitalization
Hospitals
Infections
Infectious diseases
Mortality
Obesity
Optimization
Overweight persons
Patient outcomes
Patients
prescription
Prescriptions
Risk analysis
Risk factors
Sepsis
Urea
Variables
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQT1wQT7FQ0CChXmjUOLbj-LgLVC0SsBKt1FvkV0QQzSKye9jfwR9mxslud6kEF25RbCeTzNj-xp75zNjrYLgX3rvMKmMynKFs5lypsqrMhY2N80JRcvLHT-XZpfxwpa52jvqimLCBHnj4cSdcOt4gjtey4tKKxgUXna28jFbGPCRolJt8x5lKY7DhosqrIUtGoF9_gnK2rl0Q97HhieRmbyZKhP23h-U_QyV35p7T--zeCBphOgj7gN2J3UN2NB9Yp9fHcHGTRNUfwxHMb_io14_Yr_MepijXdZtIl_BB7xa0QgDT8G3Vpyhz2GgpBqCVWZilLB_4vFqiRcYe2g7mAwNrP1T4ErEPRBjPFQDbBZhRDDzlnthrOB9jvNBHxnfDEOmXNvSBIhfXj9nl6fuLt2fZeBZD5lXOl5nVwfvcI8AoGiVMqbg1gTvufUSHq9EOr5XkwRfEwGZtqKRAV6xxuS8aK0rxhB10iy4-ZZBrHTTaTrAmyhhK4xGilg4bGCVsFSeMb_RS-5GonM7L-F6jw0K6rG_rcsLebNv8GGg6_lp7Rure1iSK7XQDDa8eDa_-l-FN2CEZS00DAYrnsVv6eoruHG3FconFGyOqx2Ghr9EbVwYhWIHFr7bF1JJC3bq4WGEd2grXiOPVhOk949uTd7-ka78manBdEl4sn_2PD3zO7ha0uJAiFw_ZwfLnKr5ABLZ0L1Nn-w2VgDgD
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELbK9sIF8RQLBRkJ9UKjxrGdxAeEdqFVi8SyglbqLfIrJYgmpdk97O_gDzPjJLsslXqLYju2MuPxzHjmG0LeOsUst9ZEWioVwQmlI2NSGeVpzLUvjeUSk5O_zNKTc_H5Ql7skNmQC4NhlYNMDILaNRZ95IdgyEgFp1ciPlz_jrBqFN6uDiU0dF9awb0PEGP3yC6IZBmPyO70aDb_tva6IApmHudd9gwHe_8Q1l-ZqkFMZMUC-M3WCRWA_G-L6_9DKP85k44fkge9MkknHfUfkR1fPyb78w6NenVAzzbJVe0B3afzDU716gn5c9rSCazrqgpgTPChTw16DujE_Vy2IfqcDtTzjqLHlk5D9g_9ulzAX_MtrWo675BZ267Ddw97w9O-3gDVtaNTjI3HnBR9RU_72C-wnWFu2kUAhot-ihGNq6fk_Pjo7ONJ1NdoiKyM2SLSmbM2tqB4JKXkKpVMK8cMs9aDIVZmBp6lYM4miMymtcsFBxOtNLFNSs1T_oyM6qb2zwmNs8xlwFNOKy-8S5UF1TU1MEBJrnM_JmygS2F7AHOso_GrAEMGaVncpuWYvFuPue7gO-7sPUVyr3si9HZ40dxcFv1OBlvJsBIMy0zkTGheGme80bkVXgsfOz0me8gsBQoIWJ6F7WqLCZh5eEXLBDQPTFT04qItNsw9Jm_WzTgSQ-Bq3yyhD16RZ6DfyzHJtphva73bLXX1I0CGZynqkemLuyd_Se4n6E4IsYp7ZLS4WfpXoHMtzOt-I_0FyHo0qg
  priority: 102
  providerName: ProQuest
Title Is Antimicrobial Dosing Adjustment Associated with Better Outcomes in Patients with Severe Obesity and Bloodstream Infections? An Exploratory Study
URI https://www.proquest.com/docview/2545919024
https://www.proquest.com/docview/2452978005
https://pubmed.ncbi.nlm.nih.gov/PMC7602836
https://doaj.org/article/14b1f01474814a3fbdbeba8c4ea4e0da
Volume 9
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3fb9MwELbG9sILYgNEYVRGQnthgTiOk_gBoXZs2pAYFazS3iL_ygjaEmhaaf07-Ie5c5KOMuCJt6q2Wyd3Z99n331HyAsrmeHG6EAJKQPYoVSgdSKCLAm5coU2XGBy8ofT5Hgavz8X5xukL3fUvcDmj9AO60lNZ5evrr8v34LBv0HECZD9NUyh1GWNtMaSef6aO2TL3xdhKF_n7vuVWTKehVmbO_OXoWv7k6fxv71Y_x5A-cuOdHSf3OtcSTpqZb9NNly1Q_YmLRf1cp-e3aRWNft0j05uWKqXD8iPk4aOYF5Xpadigh96V-O5AR3Zr4vGx57TXnbOUjyvpWOf-0M_Luagp66hZUUnLS9r03b47MAyHO2qDVBVWTrGyHjMSFFX9KSL_ALkDP9N2_g_f81PMZ5x-ZBMjw7PDo6DrkJDYETI5oFKrTGhAbcjKgSXiWBKWqaZMQ5gWJFq-CxiZk2EvGxK2SzmANAKHZqoUDzhj8hmVVfuMaFhmtoUNMoq6WJnE2nAcU00DJCCq8wNCOvlkpuOvhyraFzmAGNQlvltWQ7Iy9WYby15xz97j1Hcq55IvO2_qGcXeWfHgJQ0KwBWpnHGYsULbbXTKjOxU7ELrRqQXVSWHBUWpmfAWE0-ApCHF7QshuZeifJe13PA6EKCYxZB8_NVM47EALjK1QvogxfkKXj3YkDSNeVbm-96S1V-8YThaYJeZPLkfzzgU3I3wiMHH8-4Szbns4V7Bn7ZXA_J1vjwdPJp6M81ht70fgInz0PB
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6V9AAXxFMECiwS9EKter1ePw4VSmirhLYhglTqzezLEETtUidC-R38H34bM2s7IVTqrTfL-_DKMzuzMzvzDSGvTco011p5UqSpBxpKekpFwksin0ubK80FJiefjKLBafjhTJxtkD9tLgyGVbYy0QlqU2r0ke-CISNS0F5B-O7ip4dVo_B2tS2hIZvSCmbPQYw1iR1HdvELTLhqb7gP9H4TBIcHk_cDr6ky4Gnhs5knY6O1r0F1BrngaSSYTA1TTGsLpkQeK3gWITM6QGwxKU0ScjAycuXrIJc84jDvLbIZogOlQzb7B6Pxp6WXB1E3Ez-ps3U4T_1d-F9TNS0RgzllDmxnTSO6wgFX1cP_IZv_6MDDe-Ruc3ilvZrb7pMNWzwg2-Ma_XqxQyerZK5qh27T8QoXe_GQ_B5WtAfrOp868CeYaL9ETwXtme_zykW705ZbrKHoIaZ9l21EP85nQCVb0WlBxzUSbFV3-GxhL1ra1DegsjC0j7H4mAMjz-mwiTUDWx2-TeuIQxdYQDGCcvGInN4ItR6TTlEW9gmhfhybGHjYyNSG1kSphqNypGBAKrhMbJewli6ZbgDTsW7HjwwMJ6RldpWWXfJ2Oeaihgu5tncfyb3siVDf7kV5-TVrJAfYZorlYMjGYcJCyXNllFUy0aGVofWN7JItZJYMBRIsT4N40FkPzEq8EmYhNLdMlDXiqcpWm6lLXi2bcSSG3BW2nEMfvJKPwZ4QXRKvMd_aetdbiuk3B1EeR3hujZ5e__GX5PZgcnKcHQ9HR8_InQBdGS5Ocot0Zpdz-xzOezP1otlUlHy56X38F1NacXE
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELfGJiFeEJ-iMMBIsBcWNY7z5YcJtXTVyqBUsEl7C_4K68SSsbRC_Tv4r_iruHOSljJpb3urajuxcuc7n_273xHy2gimudbKk5EQHngo6SkVR14a-1zaXGkeYXLyp3F8cBx-OIlONsifNhcGYZWtTXSG2pQaz8i7EMhEArxXEHbzBhYxGQzfXfz0sIIU3rS25TRkU2bB7Dm6sSbJ49AufkE4V-2NBiD7N0Ew3D96f-A1FQc8Hfls5snEaO1rcKNBHnERR0wKwxTT2kJYkScKfkchMzpAnjEpTRpyCDhy5esglzzm8NxbZCsBrw-B4FZ_fzz5sjzxQQbO1E_rzB3Ohd-FbzdV0xL5mAVzxDtr3tEVEbjqKv6Hb_7jD4f3yN1mI0t7tebdJxu2eEB2JjUT9mKXHq0Su6pdukMnK47sxUPye1TRHszrfOqIoOBBgxJPLWjPnM0rh3ynreZYQ_G0mPZd5hH9PJ-BxGxFpwWd1KywVd3hq4V1aWlT64DKwtA-4vIxH0ae01GDO4O4Hd5Na_ShAxlQRFMuHpHjG5HWY7JZlIV9QqifJCYBfTZS2NCaWGjYNscKBoiIy9R2CGvlkumGPB1rePzIIIhCWWZXZdkhb5djLmrqkGt791Hcy55I--3-KC-_Z40VgThNsRyC2iRMWSh5royySqY6tDK0vpEdso3KkqFxgulpMBU660GIidfDLITmVomyxlRV2WphdcirZTOORPhdYcs59MHr-QRii6hDkjXlW5vveksxPXV05UmMe9j46fUvf0luw3rOPo7Gh8_InQBPNRxkcptszi7n9jls_WbqRbOmKPl208v4L13KdbU
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Is+Antimicrobial+Dosing+Adjustment+Associated+with+Better+Outcomes+in+Patients+with+Severe+Obesity+and+Bloodstream+Infections%3F+An+Exploratory+Study&rft.jtitle=Antibiotics+%28Basel%29&rft.au=St%C3%A9phanie+Sirard&rft.au=Claire+Nour+Abou+Chakra&rft.au=Marie-France+Langlois&rft.au=Julie+Perron&rft.date=2020-10-01&rft.pub=MDPI+AG&rft.eissn=2079-6382&rft.volume=9&rft.issue=10&rft.spage=707&rft_id=info:doi/10.3390%2Fantibiotics9100707&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_14b1f01474814a3fbdbeba8c4ea4e0da
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2079-6382&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2079-6382&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2079-6382&client=summon